Ramelteon: a review of its use in insomnia.

Drugs
Dene Simpson, Monique P Curran

Abstract

Ramelteon (Rozerem) is the first melatonin receptor agonist to be approved for the treatment of insomnia; it is not classified as a controlled substance. In patients with chronic insomnia, objectively assessed latency to persistent sleep (LPS) at week 1 was improved with oral ramelteon 8 mg administered 30 minutes before bedtime, compared with placebo, and this effect was maintained throughout the duration of 5-week and 6-month clinical studies. Subjectively assessed sleep latency (sSL) improved in some, but not all, studies. When a statistically significant improvement in sSL occurred at week 1, the effect was maintained throughout the duration of the 5-week studies, but not at all timepoints throughout a 6-month study. Improvements in objectively assessed total sleep time (TST) and sleep efficiency (SE) were only reported during the first week of treatment. Improvements in other objective or subjective measures of sleep were not consistent. Ramelteon was generally well tolerated, did not impair next-day cognitive or motor performance and was not associated with withdrawal symptoms, rebound insomnia or abuse potential. Thus, ramelteon provides a well tolerated option for the treatment of patients with insomnia characterized by...Continue Reading

References

Oct 21, 2004·Brain Research·Nobuhito YukuhiroMasaomi Miyamoto
Feb 8, 2005·Neuropharmacology·Koki KatoMasaomi Miyamoto
Aug 27, 2005·The New England Journal of Medicine·Michael H Silber
Oct 4, 2006·Archives of General Psychiatry·Matthew W JohnsonRoland R Griffiths
Dec 13, 2006·Clinical Therapeutics·Nancy L Borja, Karen L Daniel
Apr 6, 2007·Nature Clinical Practice. Neurology·Seithikurippu R Pandi-PerumalDaniel P Cardinali
May 24, 2007·Current Medical Research and Opinion·Thomas RothJeffrey Zhang
Nov 13, 2007·The American Journal of Geriatric Pharmacotherapy·Louis J MiniJeff Zhang

❮ Previous
Next ❯

Citations

Aug 2, 2011·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Tetsuya UekiMikiro Nakashima
Jun 27, 2015·Journal of Clinical Psychopharmacology·Shoko MiuraJun Horiguchi
Mar 7, 2020·Cells·Enrico MorettiRita Rezzani
Aug 1, 2020·Antioxidants·Nadia SadanandanCesar V Borlongan
Jun 3, 2009·Journal of Pineal Research·Michel HoebertMarcel G Smits
Jul 13, 2011·Journal of Assisted Reproduction and Genetics·Ozlem Gun EryilmazNedim Cicek
Feb 9, 2012·Current Neurology and Neuroscience Reports·Qiuping Pearl ZhouKathy C Richards
Jun 21, 2014·American Journal of Alzheimer's Disease and Other Dementias·Dwaipayan ChakrabortiRajesh R Tampi
Jul 2, 2009·Advances in Therapy·Seithikurippu R Pandi-PerumalDaniel P Cardinali
Sep 5, 2009·Menopause : the Journal of the North American Menopause Society·Susan C BolgeChristopher L Drake
May 24, 2013·International Journal of Molecular Sciences·Kazutaka ShinozukaCesar V Borlongan
Sep 10, 2020·Expert Opinion on Drug Metabolism & Toxicology·Clemens MuehlanJasper Dingemanse
May 19, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·R Scott Obach, Tim F Ryder
Jan 1, 2012·Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·Hiroshige Fujishiro
Jan 3, 2013·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Motohide FuruyaJun Horiguchi
Oct 27, 2015·Cell Transplantation·Nate WatsonCesar V Borlongan
Aug 26, 2009·Geriatrics & Gerontology International·Arne Fetveit
Oct 1, 2021·Chemical Biology & Drug Design·Bhavna SarohaSuresh Kumar

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved